Accurate detection of SARS-CoV-2, the pathogen causing the global pandemic of COVID-
19, is essential for disease surveillance and control. Quantitative reverse transcription PCR …

In patients with moderate-to-severe COVID-19 pneumonia, an aberrant post-viral alveolitis
with excessive inflammatory responses and immunothrombosis underpins use of …

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) not only affects the
respiratory tract but also causes neurological symptoms such as loss of smell and taste …

SARS-CoV-2 viremia at admission is associated with high risk for mortality. However,
longitudinal data on viremia duration are limited. Viremic patients hospitalized for COVID-19 …

Clinical knowledge about SARS-CoV-2 infection mechanisms and COVID-19
pathophysiology have enormously increased during the pandemic. Nevertheless, because …

Studies related to clinical diagnosis and research of SARS‐CoV‐2 are important in the
current pandemic era. Although molecular biology has emphasised the importance of …

In this Review, we analysed the prevalence of viraemia during infection with SARS-CoV-2
and other relevant respiratory viruses, including other human coronaviruses such as MERS …

Early kinetics of SARS‐CoV‐2 viral load (VL) in plasma determined by quantitative reverse‐
transcription polymerase chain reaction (RT‐PCR) was evaluated as a predictor of poor …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA loads in
patient specimens may act as a clinical outcome predictor in critically ill patients with …

Background Both severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viremia
and nasopharyngeal viral load have been suggested to be predictors of unfavorable …